FDA Law Blog

JANUARY 6, 2022

Wasserstein — “EKRA” refers to the Eliminating Kickbacks in Recovery Act, which was part of the Substance Use – Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018. S&G Labs has no contractual relationships with the entities that referred clients to S&G Labs. EKRA Issue.

Lab Testing 52

Lab Testing Individual Referral Patient-Centered 52

FDA Law Blog

JANUARY 6, 2022

Wasserstein — “EKRA” refers to the Eliminating Kickbacks in Recovery Act, which was part of the Substance Use – Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018. S&G Labs has no contractual relationships with the entities that referred clients to S&G Labs. EKRA Issue.

Lab Testing 40

Lab Testing Individual Referral Patient-Centered 40

GeriPal

DECEMBER 5, 2024

So we take that science and we apply it to something that’s very messy and chaotic, like a human being or a community or a population. I think it started off from a need, a hunger in the community. But I really wanted this project to be a love letter to that community. A love letter kind of back to my community.

IT 107

IT Community Patients Families 107

GeriPal

FEBRUARY 27, 2025

But back in 2019, there was a lot of disagreement in our group about whether for a patient with cancer and cancer related pain and a substance use disorder, whether palliative care was the appropriate specialty to care for those patients. Widera and Smith have no relationships to disclose. And I see everybody’s nodding to that.

Patients 73

Patients Clinic Patient-Centered Illness 73